TPG to buy generic drugmaker Par for $1.9 billion

Previous Post: nbsp

TPG to buy generic drugmaker Par for $1.9 billion

Reuters – Private equity firm TPG said on Monday it would acquire U.S.-based Par Pharmaceutical Cos Inc for $1.9 billion, the latest acquisition in the generic drug industry. The $50-a-share deal represents a nearly 37 percent premium over Par’s closing price on Friday. Read article

Tags: , ,

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes